• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

希佩尔-林道肿瘤抑制因子在肾肿瘤发生过程中调控依赖于N6-甲基腺苷(m6A)的基因表达。

Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.

作者信息

Zhang Cheng, Yu Miaomiao, Hepperla Austin J, Zhang Zhao, Raj Rishi, Zhong Hua, Zhou Jin, Hu Lianxin, Fang Jun, Liu Hongyi, Liang Qian, Jia Liwei, Liao Chengheng, Xi Sichuan, Simon Jeremy M, Xu Kexin, Liu Zhijie, Nam Yunsun, Kapur Payal, Zhang Qing

机构信息

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Lineberger Comprehensive Cancer Center, University of North Carolina (UNC) School of Medicine, Chapel Hill, North Carolina, USA.

出版信息

J Clin Invest. 2024 Apr 15;134(8):e175703. doi: 10.1172/JCI175703.

DOI:10.1172/JCI175703
PMID:38618952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11014668/
Abstract

N6-Methyladenosine (m6A) is the most abundant posttranscriptional modification, and its contribution to cancer evolution has recently been appreciated. Renal cancer is the most common adult genitourinary cancer, approximately 85% of which is accounted for by the clear cell renal cell carcinoma (ccRCC) subtype characterized by VHL loss. However, it is unclear whether VHL loss in ccRCC affects m6A patterns. In this study, we demonstrate that VHL binds and promotes METTL3/METTL14 complex formation while VHL depletion suppresses m6A modification, which is distinctive from its canonical E3 ligase role. m6A RNA immunoprecipitation sequencing (RIP-Seq) coupled with RNA-Seq allows us to identify a selection of genes whose expression may be regulated by VHL-m6A signaling. Specifically, PIK3R3 is identified to be a critical gene whose mRNA stability is regulated by VHL in a m6A-dependent but HIF-independent manner. Functionally, PIK3R3 depletion promotes renal cancer cell growth and orthotopic tumor growth while its overexpression leads to decreased tumorigenesis. Mechanistically, the VHL-m6A-regulated PIK3R3 suppresses tumor growth by restraining PI3K/AKT activity. Taken together, we propose a mechanism by which VHL regulates m6A through modulation of METTL3/METTL14 complex formation, thereby promoting PIK3R3 mRNA stability and protein levels that are critical for regulating ccRCC tumorigenesis.

摘要

N6-甲基腺苷(m6A)是最丰富的转录后修饰,其对癌症进展的作用最近已得到认可。肾癌是最常见的成人泌尿生殖系统癌症,其中约85%由以VHL缺失为特征的透明细胞肾细胞癌(ccRCC)亚型引起。然而,尚不清楚ccRCC中VHL缺失是否会影响m6A模式。在本研究中,我们证明VHL结合并促进METTL3/METTL14复合物的形成,而VHL缺失则抑制m6A修饰,这与其经典的E3连接酶作用不同。m6A RNA免疫沉淀测序(RIP-Seq)与RNA测序相结合,使我们能够鉴定出一系列其表达可能受VHL-m6A信号传导调节的基因。具体而言,PIK3R3被确定为一个关键基因,其mRNA稳定性以m6A依赖但HIF独立的方式受VHL调节。在功能上,PIK3R3缺失促进肾癌细胞生长和原位肿瘤生长,而其过表达则导致肿瘤发生减少。机制上,VHL-m6A调节的PIK3R3通过抑制PI3K/AKT活性来抑制肿瘤生长。综上所述,我们提出了一种机制,即VHL通过调节METTL3/METTL14复合物的形成来调节m6A,从而促进对调节ccRCC肿瘤发生至关重要的PIK3R3 mRNA稳定性和蛋白质水平。

相似文献

1
Von Hippel Lindau tumor suppressor controls m6A-dependent gene expression in renal tumorigenesis.希佩尔-林道肿瘤抑制因子在肾肿瘤发生过程中调控依赖于N6-甲基腺苷(m6A)的基因表达。
J Clin Invest. 2024 Apr 15;134(8):e175703. doi: 10.1172/JCI175703.
2
VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.VHL调控透明细胞肾细胞癌中的m6A修饰和PIK3R3 mRNA稳定性。
J Clin Invest. 2024 Apr 15;134(8):e179560. doi: 10.1172/JCI179560.
3
METTL14-mediated N-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma.METTL14 介导的 ITGB4 mRNA 的 N6-甲基腺苷修饰抑制透明细胞肾细胞癌的转移。
Cell Commun Signal. 2022 Mar 19;20(1):36. doi: 10.1186/s12964-022-00831-5.
4
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C.von Hippel-Lindau 肿瘤抑制蛋白通过组蛋白去甲基酶 JARID1C 调节基因表达和肿瘤生长。
Oncogene. 2012 Feb 9;31(6):776-86. doi: 10.1038/onc.2011.266. Epub 2011 Jul 4.
5
PTEN suppression of YY1 induces HIF-2 activity in von-Hippel-Lindau-null renal-cell carcinoma.PTEN 抑制 YY1 诱导 von-Hippel-Lindau 缺失型肾细胞癌中的 HIF-2 活性。
Cancer Biol Ther. 2009 Jul;8(14):1389-401. doi: 10.4161/cbt.8.14.8880. Epub 2009 Jul 30.
6
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.肾透明细胞癌程序性死亡配体 1 是缺氧诱导因子-2α的新的直接靶标,受 von Hippel-Lindau 基因突变状态调控。
Eur Urol. 2016 Oct;70(4):623-632. doi: 10.1016/j.eururo.2015.11.029. Epub 2015 Dec 23.
7
METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.METTL14 介导的 Pten mRNA N6-甲基腺苷修饰抑制肾透明细胞癌肿瘤进展。
Br J Cancer. 2022 Jul;127(1):30-42. doi: 10.1038/s41416-022-01757-y. Epub 2022 Mar 5.
8
METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination.METTL14介导的ZFP14的m6A修饰通过促进STAT3泛素化抑制肾透明细胞癌进展。
Clin Transl Med. 2025 Feb;15(2):e70232. doi: 10.1002/ctm2.70232.
9
Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.铁螯合对透明细胞肾细胞癌的抑制作用及其对 VHL 失活的依赖性。
Free Radic Biol Med. 2019 Mar;133:295-309. doi: 10.1016/j.freeradbiomed.2018.12.013. Epub 2018 Dec 13.
10
METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.METTL3在子宫内膜样上皮性卵巢癌中独立于METTl14和WTAP调节m6A。
Cell Biol Int. 2020 Dec;44(12):2524-2531. doi: 10.1002/cbin.11459. Epub 2020 Sep 11.

引用本文的文献

1
FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway.FTO 通过介导 BUB1 的 m6A 修饰并靶向 TGF-βR1 激活 TGF-β 信号通路促进肝细胞癌进展。
J Clin Transl Hepatol. 2025 May 28;13(5):385-394. doi: 10.14218/JCTH.2025.00007. Epub 2025 Apr 18.
2
The Hippo pathway effector YAP inhibits NF-κB signaling and ccRCC growth by opposing ZHX2.河马通路效应因子YAP通过对抗ZHX2来抑制核因子-κB信号传导和肾透明细胞癌生长。
J Biol Chem. 2025 Mar 20;301(5):108430. doi: 10.1016/j.jbc.2025.108430.
3
Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC).

本文引用的文献

1
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer.m6A 修饰在调控癌症中 PI3K/AKT 信号通路中的作用。
J Transl Med. 2023 Nov 1;21(1):774. doi: 10.1186/s12967-023-04651-0.
2
Histone H3 proline 16 hydroxylation regulates mammalian gene expression.组蛋白 H3 脯氨酸 16 羟化调控哺乳动物基因表达。
Nat Genet. 2022 Nov;54(11):1721-1735. doi: 10.1038/s41588-022-01212-x. Epub 2022 Nov 8.
3
An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma.
解析SETD2介导的H3K36me3与RNA N6-甲基腺苷在肾透明细胞癌(ccRCC)中的相互作用。
Epigenetics. 2025 Dec;20(1):2456418. doi: 10.1080/15592294.2025.2456418. Epub 2025 Jan 28.
4
Establishment of RNA modification regulators index predicting clinical outcomes and immune relevance of kidney cancer patients.建立预测肾癌患者临床结局和免疫相关性的RNA修饰调节因子指数
Heliyon. 2024 Oct 5;10(20):e39021. doi: 10.1016/j.heliyon.2024.e39021. eCollection 2024 Oct 30.
5
METTL Family in Healthy and Disease.METTL 家族在健康与疾病中的作用
Mol Biomed. 2024 Aug 19;5(1):33. doi: 10.1186/s43556-024-00194-y.
6
The Hippo pathway effector YAP inhibits NF-κB signaling and ccRCC growth by opposing ZHX2.河马通路效应因子YAP通过对抗ZHX2来抑制核因子κB信号传导和肾透明细胞癌生长。
bioRxiv. 2025 Feb 7:2024.06.21.600079. doi: 10.1101/2024.06.21.600079.
7
VHL governs m6A modification and PIK3R3 mRNA stability in clear cell renal cell carcinomas.VHL调控透明细胞肾细胞癌中的m6A修饰和PIK3R3 mRNA稳定性。
J Clin Invest. 2024 Apr 15;134(8):e179560. doi: 10.1172/JCI179560.
致癌 JMJD6-DGAT1 轴调节透明细胞肾细胞癌中脂滴形成的表观遗传调控。
Mol Cell. 2022 Aug 18;82(16):3030-3044.e8. doi: 10.1016/j.molcel.2022.06.003. Epub 2022 Jun 27.
4
The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology.胰岛素样生长因子 2 mRNA 结合蛋白在女性生殖病理生理学中的作用。
Reprod Biol Endocrinol. 2022 Jun 15;20(1):89. doi: 10.1186/s12958-022-00960-z.
5
Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors.在人类肿瘤中分析 PIK3R1 和 PIK3R2 作用的泛癌症分析。
Sci Rep. 2022 Apr 8;12(1):5924. doi: 10.1038/s41598-022-09889-0.
6
METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N-methyladenosine modification of PD-L1 mRNA in breast cancer.METTL3/IGF2BP3 轴通过上调乳腺癌中 PD-L1 mRNA 的 N6-甲基腺苷修饰来抑制肿瘤免疫监视。
Mol Cancer. 2022 Feb 23;21(1):60. doi: 10.1186/s12943-021-01447-y.
7
Dynamic regulation and functions of mRNA m6A modification.mRNA m6A修饰的动态调控及其功能
Cancer Cell Int. 2022 Jan 29;22(1):48. doi: 10.1186/s12935-022-02452-x.
8
A renal cell carcinoma tumorgraft platform to advance precision medicine.建立一个肾透明细胞癌肿瘤移植平台以推进精准医疗
Cell Rep. 2021 Nov 23;37(8):110055. doi: 10.1016/j.celrep.2021.110055.
9
The RNA N -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer.RNA N6 -甲基腺苷修饰酶 HNRNPA2B1 参与非小细胞肺癌的发生发展。
Clin Exp Pharmacol Physiol. 2022 Mar;49(3):329-340. doi: 10.1111/1440-1681.13608. Epub 2021 Nov 14.
10
Aberrant activation of m6A demethylase FTO renders HIF2α clear cell renal cell carcinoma sensitive to BRD9 inhibitors.m6A 去甲基化酶 FTO 的异常激活使 HIF2α 透明细胞肾细胞癌对 BRD9 抑制剂敏感。
Sci Transl Med. 2021 Sep 29;13(613):eabf6045. doi: 10.1126/scitranslmed.abf6045.